Recent Quotes
My Watchlist
Indicators
PennEnergy Stock Watch
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

238.46 -2.85 (-1.18%)
Official Closing Price Updated: 7:00 PM EDT, Apr 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,354,529
Open 242.00
Bid (Size) 238.50 (300)
Ask (Size) 239.00 (100)
Prev. Close 241.31
Today's Range 237.91 - 242.26
52wk Range 145.13 - 251.71
Shares Outstanding 2,628,679,824
Dividend Yield 2.18%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
The $100 Billion Pivot: Why Johnson & Johnson Is My Top Dividend King to Buy in 2026 ↗
This stock might help you sleep more easily at night. 
Via The Motley Fool
Topics Economy Intellectual Property Lawsuit
News headline image
4 Stocks That Can Fund Decades of Passive Income -- Buy Them While They're Down ↗
These defensive consumer stocks are flashing buy signals while the market chases AI hype. 
Via The Motley Fool
Topics Artificial Intelligence

Performance

YTD
+15.0%
+15.0%
1 Month
-1.9%
-1.9%
3 Month
+16.7%
+16.7%
6 Month
+25.0%
+25.0%
1 Year
+60.4%
+60.4%

More News

Read More
News headline image
Stocks Rallied After President Donald Trump's Ceasefire in Iran. Here's How to Invest Now. ↗
Via The Motley Fool
Topics Government Stocks
News headline image
Johnson & Johnson Showcases New Clinical Data for TECNIS PureSee IOL at ASCRS 2026 Demonstrating Excellent Contrast Sensitivity and Extended Range of Vision
From Johnson & Johnson
Via Business Wire
News headline image
Could Buying This Dividend Pharma Stock Today Set You Up for Life? ↗
Via The Motley Fool
Topics Stocks
Robotics and AI in Drug Manufacturing: May Unlock Efficiency Gains, Long-Term Value
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
The Teleflex Pivot: Inside the $1 Billion Share Buyback and Strategic Breakup
Via Finterra
Topics Economy World Trade
News headline image
ImmunityBio (IBRX): From R&D Speculation to Record Commercial Revenue
Via Finterra
Topics Economy World Trade
News headline image
Johnson & Johnson Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call ↗
Via Benzinga
News headline image
Robotics and AI in Drug Manufacturing: May Unlock Efficiency Gains, Long-Term Value
From AINewsWire
Via GlobeNewswire
News headline image
These 3 Beaten-Down Stocks Haven't Been This Cheap in Over a Decade ↗
Via The Motley Fool
Topics Economy World Trade
News headline image
This Healthcare Stock Has No Debt and a Near-Monopoly in Its Market ↗
Via The Motley Fool
News headline image
Martin Capital Dumps $4.5 Million in Robert Half Shares After a Brutal Year for the Staffing Sector ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Johnson & Johnson Advances Pulsed Field Ablation Portfolio with the Launch of VARIPULSE Pro in Europe
From Johnson & Johnson
Via Business Wire
News headline image
You'll Never Guess Which Healthcare Stock Delivered the Best First-Quarter Performance in the S&P 500. ↗
Via The Motley Fool
Topics Artificial Intelligence Economy Stocks
News headline image
Robotic Revolution in the Electrophysiology Lab: FDA Clears Stereotaxis Synchrony System
Via MarketMinute
Topics Artificial Intelligence
News headline image
Stereotaxis Secures FDA Clearance for Synchrony™ System, Completing Its Vision for the Robotic "Digital Cockpit"
Via MarketMinute
News headline image
The "Liberation Day" Shockwave: US Finalizes 100% Tariffs on Branded Pharmaceutical Imports
Via MarketMinute
Topics Economy World Trade
News headline image
Gilead Extends Tender Offer for Arcellx as Biotech M&A Sentiment Faces a Reality Check
Via MarketMinute
News headline image
Better Healthcare Stock to Own in a Recession: Defensive or Growth? ↗
Via The Motley Fool
Topics Economy Energy
News headline image
JEPI vs. JEPQ: Which Is the Better Buy in April? ↗
Via The Motley Fool
Topics Bonds ETFs Economy
News headline image
Comparing 2 Healthcare Giants: Which Dividend Aristocrat Will Keep Paying Out for Generations to Come?
Via Barchart.com
News headline image
Med-Tech Resilience: AngioDynamics Pivot Pays Off with Double-Digit Growth and Profitability
Via MarketMinute
Topics Economy Retirement
News headline image
This Healthcare Stock Barely Flinches During Market Sell-Offs ↗
Via The Motley Fool
Topics Economy Stocks
News headline image
Stagflation Fears Are Back: These 3 Stocks Can Help You Ride Out the Storm ↗
Via The Motley Fool
Topics Economy

Frequently Asked Questions

Is Johnson & Johnson publicly traded?
Yes, Johnson & Johnson is publicly traded.
What exchange does Johnson & Johnson trade on?
Johnson & Johnson trades on the New York Stock Exchange
What is the ticker symbol for Johnson & Johnson?
The ticker symbol for Johnson & Johnson is JNJ on the New York Stock Exchange
What is the current price of Johnson & Johnson?
The current price of Johnson & Johnson is 238.46
When was Johnson & Johnson last traded?
The last trade of Johnson & Johnson was at 04/10/26 07:00 PM ET
What is the market capitalization of Johnson & Johnson?
The market capitalization of Johnson & Johnson is 626.83B
How many shares of Johnson & Johnson are outstanding?
Johnson & Johnson has 627B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>